Info
p16
p16 is a protein that plays a crucial role in head and neck cancer (HNC). Here are some key points about p16 in HNC:
-
p16 as a Surrogate Marker of HPV Infection:
- HPV-positive tumors are less likely to harbor p53 mutations[1].
-
p16 Expression and Clinicopathological Parameters:
- A study found a statistically significant direct association between p16 expression and age, site of the tumor, abnormal sexual habits, and lymph node involvement[1].
- p16 expression was positively correlated with sex and site of the primary tumor, but not with age[1].
-
- Discordance between p16 and HPV DNA or RNA status exists in some patients with oropharyngeal cancer, which has significant implications for prognosis[2].
- The controversy surrounding the prognostic significance of this discordant group has been addressed through a large, multicentre study that found substantial variations in survival outcomes[2].
-
p16 in Oropharyngeal Cancer:
- p16 immunohistochemistry is widely used as a biomarker assay for inferring HPV causation in oropharyngeal cancer[2].
- The study highlights the importance of accurately classifying patients with oropharyngeal cancer to guide treatment decisions and patient counselling[2].
These findings emphasize the importance of p16 expression in understanding the etiology and prognosis of head and neck cancers, particularly in the context of HPV infection.
Citations: [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272494/ [2] https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2823%2900013-X/fulltext [3] https://www.mdpi.com/1959460